Uniklinik Köln
Harshal Nemade is currently a Postdoctoral Researcher at Uniklinik Köln since July 2020, where Harshal explores the role of MLKL induced-necroptosis in the development of abdominal aortic aneurysm (AAA). Prior to this, Harshal worked as a Postdoctoral Scientist at the University of Cologne from January 2013 to July 2020, where Harshal extensively utilized the CRISPR-Cas9 system for various projects related to iPSCs and epigenetics. Harshal also worked as a Research Associate at Lupin Pharmaceuticals from March 2010 to August 2012, focusing on type I diabetes mellitus project. Harshal holds a Ph.D. from the University of Cologne, a Master's degree in Biochemistry from Savitribai Phule Pune University, and a Bachelor's degree in Chemistry.
Uniklinik Köln
Working with Cologne University Hospital means developing the future – the future of medicine, the future welfare of patients and the future of your career. Our 1.500-bed-hospital is obliged to provide maximal medical care. We are passionate about a scientific-oriented innovative medicine. Our constant economic growth is one aspect of our operations but we strongly focus on our social responsibility in medical research, education and healthcare as well. Cologne University Hospital provides not only top of the range medical care but is also one of Cologne's biggest employers. We are facing our social responsibility every single day. With 59 clinics and institutes and more than 10.000 employees we are among the top university hospitals in Germany.